Personalizing medicine: the single nucleotide polymorphism and the treatment of status asthmaticus.
Stevens
Jessica
J
Notterman
Daniel
D
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000494:pharmacology*; D001741:Black or African American / Q000235:genetics*; D000628:Aminophylline / Q000008:administration & dosage / Q000494:pharmacology; D002648:Child; D004359:Drug Therapy, Combination; D006239:Haplotypes; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology; D020641:Polymorphism, Single Nucleotide; D018343:Receptors, Adrenergic, beta-2 / Q000235:genetics*; D013224:Status Asthmaticus / Q000188:drug therapy* / Q000208:ethnology / Q000235:genetics*
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D010726:Phosphodiesterase Inhibitors; D018343:Receptors, Adrenergic, beta-2; D000628:Aminophylline